The Falsified Medicines Directive will become effective on 9 February 2019. The Directive introduces tougher rules to ensure medicines are safe and that the trade in medicines is rigorously controlled. This will have an impact on all practices which, therefore, need to prepare for implementation in order to demonstrate compliance with the Directive. GPC has issued guidance on the BMA website:
GPC England Executive Team member Dr Krishna Kasaraneni has also written a blog on Brexit and the Falsified Medicines Directive available here.
Select from the drop-down list below to view an item from our news archives.